Transplant News stories from January, 2017

Northwell Health’s Feinstein Institute discovers cancer treatment for transplant patients

By Northwell Health
Published on January 18, 2017

Kenar D. Jhaveri, MD, and Richard Barnett, MD, Feinstein Institute for Medical Research scientists and Northwell Health Department of Internal Medicine nephrologists, published a Letter to the Editor in the prestigious New England Journal of Medicine, which profiles a novel drug combination with the potential to help prevent rejection of a donor kidney in transplant

Read More

U of M research could help doctors predict kidney transplant rejection

Currently, around 12 to 15 per cent of patients experience kidney rejection in the first year after a transplant. Ho has been researching a protein found in urine that detects rejection much earlier than the current routine tests.

“We are hoping to prove that by using this test that we can detect rejection earlier and treat it earlier, and improve their outcomes at 12 months and hopefully over the long term,” Ho said.

Following a kidney transplant, patients’ urine will be tested for the CXCL10 protein. If it shows up there will be biopsy, and if that shows signs of rejection, the patient will receive treatment.

Read More